About the Journal

The Journal of Cancer Therapeutics and Immunotherapy is a peer-reviewed, open- access, quarterly journal publishing the latest findings in all the areas related to tumor immunology and cancer immunotherapy. The journal provides a platform for researchers, academics, and practitioners to share their knowledge and ideas on a wide range of topics, including novel cancer therapeutics, targeted therapies, chemotherapy, and immunotherapy, cancer biomarkers and diagnostics, cancer immunology and immune-oncology, cancer prevention and early detection, clinical trials in cancer therapy and immunotherapy.

The journal strictly follows a double-blind peer review policy for an unbiased review process while ensuring a responsible and ethical environment.

To submit your manuscript, kindly register at https://www.reseaprojournals.com/emsystem/register_user